Literature DB >> 10458303

Uveal non-Hodgkin's lymphoma with epibulbar extension simulating choroidal effusion syndrome.

F G Holz1, H V Boehmer, G Mechtersheimer, G Ott, H E Völcker.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10458303     DOI: 10.1097/00006982-199919040-00015

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  6 in total

Review 1.  [Primary uveal lymphoma effectively treated with radiotherapy: a case report and literature review].

Authors:  Ruo-Xin Wu; Tao Yang; Zhu-Ping Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

2.  Diagnosis of a primary uveal extranodal marginal zone B-cell lymphoma by chorioretinal biopsy: case report.

Authors:  Sarah E Coupland; Antonia Joussen; Gerasimos Anastassiou; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-07       Impact factor: 3.117

3.  Uveal effusion syndrome caused by choroidal invasion of malignant lymphoma.

Authors:  Satoru Kase; Wataru Saito; Akari Saito; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2010-02-12       Impact factor: 2.447

4.  [Diagnostics and treatment of choroidal lymphoma].

Authors:  D Doycheva; M Zierhut; D Süsskind; K U Bartz-Schmidt; C Deuter
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

Review 5.  Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features.

Authors:  Sarah E Coupland; Heinrich Heimann; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-29       Impact factor: 3.117

6.  Primary extranodal marginal zone lymphoma of the uvea associated with massive diffuse epibulbar extension and focal infiltration of the optic nerve and meninges, clinically presented as uveitis masquerade syndrome: a case report.

Authors:  D M Rasić; Z Stanković; T Terzić; D Kovacević; Z Koturović; V Marković
Journal:  Med Oncol       Date:  2009-10-09       Impact factor: 3.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.